Breakthrough EU approval for Dupixent offers new hope for children with eosinophilic esophagitis

Pallavi Madhiraju- November 8, 2024 0

The European Medicines Agency (EMA) has granted approval for Dupixent, a therapy developed by Sanofi and Regeneron, to treat eosinophilic esophagitis (EoE) in children as ... Read More

Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis

Raghuram Kadari- February 1, 2023 0

French pharmaceutical company Sanofi and Regeneron, an American biotechnology company, have received the approval of the European Commission (EC) to market their Dupixent (dupilumab) injection ... Read More